Literature DB >> 8309467

[Cryopreservation of thyroid pieces--optimal freezing condition and recovery].

Y Kitamura1, K Shimizu, M Nagahama, T Shoji.   

Abstract

We have studied the cryopreservation of thyroid pieces for the purpose of autotransplantation. In this paper, the optimal freezing condition was investigated by comparing the survival cells of the cryopreserved thyroid pieces under various freezing conditions, including cooling rate, freezing medium, cryoprotectant, size of pieces and prefreezing incubation. The recovery regarded as survival rate was also evaluated. Based on the results, the optimal freezing condition was that 1 mm 3 of the thyroid pieces in the freezing medium, consisted of culture medium supplemented with 10% of fetal bovine serum and 10% of dimethylsulfoxide, were cooled slowly until -80 degrees C with prefreezing incubation at 4 degrees C for 1 hour and kept in liquid nitrogen for preservation. The number of survival cells under the optimal condition was 1.24-2.03 (1.71 +/- 0.40) x 10(6)/0.1 g tissue, and recovery was 25.2-58.0 (45.5 +/- 14.6)%. This high survival rate suggests the possibility that the cryopreserved thyroid pieces are utilized as the autografts maintaining the intact follicles.

Entities:  

Mesh:

Year:  1994        PMID: 8309467

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  2 in total

1.  Xenotransplantation of cultured newborn pig thyroid tissue for the treatment of post-radioiodine hypothyroidism in rats.

Authors:  I Pasteur; N Tronko; I Drozdovich; S Donich; L Voitenko
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

2.  Cryopreserved Rat Thyroid Autotransplantation in the Treatment of Postoperative Hypothyroidism.

Authors:  Marcel Vasconcellos; Amabile Maran Carra; Olavo Borges Franco; Wagner Baetas-da-Cruz; Manoel Luiz Ferreira; Paulo Cesar Silva; Sergio Augusto Lopes de Souza; Leandro Miranda-Alves; Denise Pires de Carvalho; Alberto Schanaider
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.